Form 4: Director Mark Verdi Receives Genpact RSU Grant
Director Equity Compensation Disclosure
Genpact Limited director Mark A. Verdi was granted 6,521 restricted share units as part of the company's 2017 Omnibus Incentive Compensation Plan.
Summary
- Director Mark A. Verdi acquired 6,521 restricted share units (RSUs) on April 23, 2026.
- The grant was issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
- Following this transaction, the reporting person's total beneficial ownership of common shares increased to 71,526.
- The RSUs were granted at a price of $0 per share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified; this is a standard equity compensation disclosure.
Risks
- Vesting of the RSUs is subject to the reporting person's continued service to the company.
Future Outlook
The RSUs are scheduled to fully vest on December 31, 2026, with settlement in common shares occurring on December 31, 2027, contingent upon continued service.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term retention and performance alignment in the professional services and IT consulting sector.
Comparison to Industry Standards
- The use of RSU grants for director compensation is consistent with standard practices among S&P 500 and mid-cap technology service firms.
- Vesting schedules of approximately 18 months are common for director-level equity retention programs.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of RSUs under the 2017 Omnibus Incentive Compensation Plan. | 04/23/2026 | Neutral; standard compensation practice. |
Stakeholder Impact
- Minimal impact on shareholders as this represents standard director compensation.
Next Steps
- Vesting of RSUs on December 31, 2026.
- Settlement of shares on December 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/23/2026 | Date of the RSU grant transaction. |
| 04/27/2026 | Date of filing. |
| 12/31/2026 | Vesting date for the granted RSUs. |
| 12/31/2027 | Settlement date for the common shares. |
Keywords
Genpact, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.